Roula Ghaoui1, Johanna Palmio1, Janice Brewer1, Monkol Lek1, Merrilee Needham1, Anni Evilä1, Peter Hackman1, Per-Harald Jonson1, Sini Penttilä1, Anna Vihola1, Sanna Huovinen1, Mikaela Lindfors1, Ryan L Davis1, Leigh Waddell1, Simran Kaur1, Con Yiannikas1, Kathryn North1, Nigel Clarke1, Daniel G MacArthur1, Carolyn M Sue2, Bjarne Udd2. 1. From the Institute for Neuroscience and Muscle Research (R.G., L.W., S.K., N.C.), Kids Research Institute, Children's Hospital at Westmead & University of Sydney, Australia; Neuromuscular Research Center, Department of Neurology (J.P., S.P., M.L., B.U.), and Department of Pathology, Fimlab Laboratories (S.H.), Tampere University Hospital and University of Tampere, Finland; Department of Pathology (J.B.), Royal North Shore Hospital, Sydney, Australia; Broad Institute of Harvard and MIT (M.L., D.G.M.), Cambridge, MA; Western Australian Neurosciences Research Institute (M.N.), University of Western Australia, Perth; Folkhälsan Institute of Genetics and Department of Medical Genetics (A.E., P.H., P.H.-J., A.V., B.U.), University of Helsinki, Finland; Department of Neurogenetics (R.L.D., C.Y., C.M.S.), Kolling Institute, Royal North Shore Hospital and University of Sydney; Murdoch Children's Research Institute (K.N.), The Royal Children's Hospital, Melbourne, Australia; Analytic and Translational Genetics Unit (M.L., D.G.M.), Massachusetts General Hospital, Boston; and Department of Neurology (B.U.), Vaasa Central Hospital, Finland. 2. From the Institute for Neuroscience and Muscle Research (R.G., L.W., S.K., N.C.), Kids Research Institute, Children's Hospital at Westmead & University of Sydney, Australia; Neuromuscular Research Center, Department of Neurology (J.P., S.P., M.L., B.U.), and Department of Pathology, Fimlab Laboratories (S.H.), Tampere University Hospital and University of Tampere, Finland; Department of Pathology (J.B.), Royal North Shore Hospital, Sydney, Australia; Broad Institute of Harvard and MIT (M.L., D.G.M.), Cambridge, MA; Western Australian Neurosciences Research Institute (M.N.), University of Western Australia, Perth; Folkhälsan Institute of Genetics and Department of Medical Genetics (A.E., P.H., P.H.-J., A.V., B.U.), University of Helsinki, Finland; Department of Neurogenetics (R.L.D., C.Y., C.M.S.), Kolling Institute, Royal North Shore Hospital and University of Sydney; Murdoch Children's Research Institute (K.N.), The Royal Children's Hospital, Melbourne, Australia; Analytic and Translational Genetics Unit (M.L., D.G.M.), Massachusetts General Hospital, Boston; and Department of Neurology (B.U.), Vaasa Central Hospital, Finland. Bjarne.udd@netikka.fi Carolyn.sue@sydney.edu.au.
Abstract
OBJECTIVE: To report novel disease and pathology due to HSPB8 mutations in 2 families with autosomal dominant distal neuromuscular disease showing both myofibrillar and rimmed vacuolar myopathy together with neurogenic changes. METHODS: We performed whole-exome sequencing (WES) in tandem with linkage analysis and candidate gene approach as well as targeted next-generation sequencing (tNGS) to identify causative mutations in 2 families with dominant rimmed vacuolar myopathy and a motor neuropathy. Pathogenic variants and familial segregation were confirmed using Sanger sequencing. RESULTS: WES and tNGS identified a heterozygous change in HSPB8 in both families: c.421A > G p.K141E in family 1 and c.151insC p.P173SfsX43 in family 2. Affected patients had a distal myopathy that showed myofibrillar aggregates and rimmed vacuoles combined with a clear neurogenic component both on biopsy and neurophysiologic studies. MRI of lower limb muscles demonstrated diffuse tissue changes early in the disease stage progressing later to fatty replacement typical of a myopathy. CONCLUSION: We expand the understanding of disease mechanisms, tissue involvement, and phenotypic outcome of HSPB8 mutations. HSPB8 is part of the chaperone-assisted selective autophagy (CASA) complex previously only associated with Charcot-Marie-Tooth type 2L (OMIM 60673) and distal hereditary motor neuronopathy type IIa. However, we now demonstrate that patients can develop a myopathy with histologic features of myofibrillar myopathy with aggregates and rimmed vacuoles, similar to the pathology in myopathies due to gene defects in other compounds of the CASA complex such as BAG3 and DNAJB6 after developing the early neurogenic effects.
OBJECTIVE: To report novel disease and pathology due to HSPB8 mutations in 2 families with autosomal dominant distal neuromuscular disease showing both myofibrillar and rimmed vacuolar myopathy together with neurogenic changes. METHODS: We performed whole-exome sequencing (WES) in tandem with linkage analysis and candidate gene approach as well as targeted next-generation sequencing (tNGS) to identify causative mutations in 2 families with dominant rimmed vacuolar myopathy and a motor neuropathy. Pathogenic variants and familial segregation were confirmed using Sanger sequencing. RESULTS: WES and tNGS identified a heterozygous change in HSPB8 in both families: c.421A > G p.K141E in family 1 and c.151insC p.P173SfsX43 in family 2. Affected patients had a distal myopathy that showed myofibrillar aggregates and rimmed vacuoles combined with a clear neurogenic component both on biopsy and neurophysiologic studies. MRI of lower limb muscles demonstrated diffuse tissue changes early in the disease stage progressing later to fatty replacement typical of a myopathy. CONCLUSION: We expand the understanding of disease mechanisms, tissue involvement, and phenotypic outcome of HSPB8 mutations. HSPB8 is part of the chaperone-assisted selective autophagy (CASA) complex previously only associated with Charcot-Marie-Tooth type 2L (OMIM 60673) and distal hereditary motor neuronopathy type IIa. However, we now demonstrate that patients can develop a myopathy with histologic features of myofibrillar myopathy with aggregates and rimmed vacuoles, similar to the pathology in myopathies due to gene defects in other compounds of the CASA complex such as BAG3 and DNAJB6 after developing the early neurogenic effects.
Authors: Sachiko Homma; Masahiro Iwasaki; G Diane Shelton; Eva Engvall; John C Reed; Shinichi Takayama Journal: Am J Pathol Date: 2006-09 Impact factor: 4.307
Authors: Roula Ghaoui; Sandra T Cooper; Monkol Lek; Kristi Jones; Alastair Corbett; Stephen W Reddel; Merrilee Needham; Christina Liang; Leigh B Waddell; Garth Nicholson; Gina O'Grady; Simranpreet Kaur; Royston Ong; Mark Davis; Carolyn M Sue; Nigel G Laing; Kathryn N North; Daniel G MacArthur; Nigel F Clarke Journal: JAMA Neurol Date: 2015-12 Impact factor: 18.302
Authors: Duygu Selcen; Francesco Muntoni; Barbara K Burton; Elena Pegoraro; Caroline Sewry; Anna V Bite; Andrew G Engel Journal: Ann Neurol Date: 2009-01 Impact factor: 10.422
Authors: Joy Irobi; Katrien Van Impe; Pavel Seeman; Albena Jordanova; Ines Dierick; Nathalie Verpoorten; Andrej Michalik; Els De Vriendt; An Jacobs; Veerle Van Gerwen; Krist'l Vennekens; Radim Mazanec; Ivailo Tournev; David Hilton-Jones; Kevin Talbot; Ivo Kremensky; Ludo Van Den Bosch; Wim Robberecht; Joël Van Vandekerckhove; Christine Van Broeckhoven; Jan Gettemans; Peter De Jonghe; Vincent Timmerman Journal: Nat Genet Date: 2004-05-02 Impact factor: 38.330
Authors: V Timmerman; P Raeymaekers; E Nelis; P De Jonghe; L Muylle; C Ceuterick; J J Martin; C Van Broeckhoven Journal: J Neurol Sci Date: 1992-05 Impact factor: 3.181
Authors: Serena Carra; Simon Alberti; Patrick A Arrigo; Justin L Benesch; Ivor J Benjamin; Wilbert Boelens; Britta Bartelt-Kirbach; Bianca J J M Brundel; Johannes Buchner; Bernd Bukau; John A Carver; Heath Ecroyd; Cecilia Emanuelsson; Stephanie Finet; Nikola Golenhofen; Pierre Goloubinoff; Nikolai Gusev; Martin Haslbeck; Lawrence E Hightower; Harm H Kampinga; Rachel E Klevit; Krzysztof Liberek; Hassane S Mchaourab; Kathryn A McMenimen; Angelo Poletti; Roy Quinlan; Sergei V Strelkov; Melinda E Toth; Elizabeth Vierling; Robert M Tanguay Journal: Cell Stress Chaperones Date: 2017-03-31 Impact factor: 3.667
Authors: Serena Carra; Simon Alberti; Justin L P Benesch; Wilbert Boelens; Johannes Buchner; John A Carver; Ciro Cecconi; Heath Ecroyd; Nikolai Gusev; Lawrence E Hightower; Rachel E Klevit; Hyun O Lee; Krzysztof Liberek; Brent Lockwood; Angelo Poletti; Vincent Timmerman; Melinda E Toth; Elizabeth Vierling; Tangchun Wu; Robert M Tanguay Journal: Cell Stress Chaperones Date: 2019-02-13 Impact factor: 3.667
Authors: Avnika A Ruparelia; Emily A McKaige; Caitlin Williams; Keith E Schulze; Margit Fuchs; Viola Oorschot; Emmanuelle Lacene; Mirella Meregalli; Clara Lee; Rita J Serrano; Emily C Baxter; Keyne Monro; Yvan Torrente; Georg Ramm; Tanya Stojkovic; Josée N Lavoie; Robert J Bryson-Richardson Journal: Autophagy Date: 2020-10-19 Impact factor: 16.016